# OnCo record nct07108309 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07108309/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07108309", "NCT07108309" ;
  schema:name "BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer"@en ;
  schema:alternateName "AREAL"@en ;
  schema:description "A phase 2 trial of BCD-236 in triple-negative breast cancer, run by Biocad, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07108309/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07108309> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2024-07-15" ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/tnbc-metastatic/> ;
  onco:companies <https://onco.cc/companies/biocad/> .
